Targeting an AML-sustaining metabolic node
- PMID: 40146158
- PMCID: PMC11969260
- DOI: 10.1182/blood.2024027768
Targeting an AML-sustaining metabolic node
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Comment on
-
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia.Blood. 2025 Mar 27;145(13):1422-1436. doi: 10.1182/blood.2024025245. Blood. 2025. PMID: 39791576 Free PMC article.
References
-
- Millman SE, Chaves-Perez A, Janaki-Raman S, et al. α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia. Blood. 2025;145(13):1422–1436. - PubMed
Publication types
LinkOut - more resources
Full Text Sources